Scope-The importance of folate-mediated one-carbon metabolism (FOCM) in colorectal carcinogenesis is emphasized by observations that high dietary folate intake is associated with decreased risk of colon cancer (CC) and its precursors. Additionally, polymorphisms in FOCMrelated genes have been repeatedly associated with risk, supporting a causal relationship between folate and colorectal carcinogenesis.
INTRODUCTION
Colorectal cancer (CRC) is one of the most common cancers worldwide [1] . The majority of cases occur sporadically, indicating that health behaviors are strongly related to disease development [2, 3] . Risk factors include Western diet, sedentary lifestyle, obesity and chronic inflammation, while physical activity and the use of NSAIDs are protective of the disease [2] [3] [4] [5] . In addition to these modifiable risk factors, genetic predisposition plays a crucial role in susceptibility to CRC [6] . Rare high penetrance mutations (e.g. in APC) confer strong risk of CRC in specific families, however, in the general population CRC is more likely to be caused by a combination of common alleles and environmental or lifestyle factors such as diet. The elucidation of gene-diet interactions is thus important to understand the full complexity of the association between nature and nurture in colorectal carcinogenesis.
Folate is a water-soluble B-vitamin that functions as a carrier of one-carbon groups. As an essential component of the folate-mediated one-carbon metabolism (FOCM), it is important for synthesizing nucleotides, such as thymidylate and purines, for DNA replication and DNA repair and for producing S-adenosylmethionine (SAM), the universal donor of methyl groups for DNA methylation [7, 8] . Folate has long been known to be important to human health and the role of B vitamins in CRC development has been studied for years.
Numerous studies have illustrated the significance of FOCM in colorectal carcinogenesis (Figure 1) , showing that extrinsic (e.g. diet) as well as intrinsic (e.g. genetic variation) factors may contribute to the risk of CRC [7] [8] [9] [10] [11] [12] . However, the exact mechanism underlying these relationships remains unclear and a combination of both seems likely. Most epidemiologic studies show a strong inverse association between folate status and colorectal neoplasia, consistently reporting that high dietary folate intake or biomarkers of folate intake are associated with a decreased risk of colon cancer or its precursors [2, 3, 7, [11] [12] [13] [14] . In addition, investigations of polymorphisms in FOCM-related genes demonstrated the relevance of these genetic variants for colon cancer risk and gene-diet interaction studies support the connection between FOCM-related genes and nutrients in colorectal carcinogenesis [7, [15] [16] [17] [18] [19] [20] . However, studies are often limited to small sample sizes and show some inconsistency. Yet the full elucidation of the complex interactions between genes and nutrients within the FOCM in colon and rectal carcinogenesis is important to build public guidelines for the general population.
We have previously reported statistically significant associations between colon cancer risk and functional polymorphisms in MTHFR and TS [21, 22] . In the present study, we have extended this work in our large case-control study to highlight further the importance of FOCM-related gene-diet interaction in susceptibility to colon cancer. We evaluated 10 common candidate polymorphisms (either non-synonymous or with defined functional impact) in serine hydroxymethyltransferase 1 
(SHMT1), dihydrofolatereductase(DHFR), DNA (cytosine-5-) methyltransferase 1(DNMT1), methylenetetrahydrofolate dehydrogenase 1(MTHFD1), methylenetetrahydrofolatereductase(MTHFR), 5-methyltetrahydrofolatehomocysteine methyltransferasereductase(MTRR), transcobalamin II(TCN2)
, and thymine-DNA glycosylase (TDG) , that show evidence for a functional impact on colon cancer risk. A major focus was the investigation of interactions of these polymorphisms with folate, methionine, vitamin B 2 , vitamin B 6 , and vitamin B 12 -nutrients that play crucial roles in FOCM -in order to identify gene-diet interactions that modify susceptibility to colon cancer.
MATERIALS AND METHODS

Study setting and design
This study is based on a large case-control study (n=1609 cases and n=1974 controls) of colon cancer. The participants were African-American, Caucasian, or Hispanic subjects from Kaiser Permanente Medical Care Program (KPMCP) of Northern California, an eight county area in Utah, and the metropolitan Twin Cities area of Minnesota.
Cases-Eligibility criteria for cases included the following: diagnosis with first-primary incident colon cancer (International Classification of Diseases for Oncology, 2 nd edition codes 18.0, 18.2-18.9) between October 1, 1991 and September 30, 1994 , between 30 and 79 years of age at time of diagnosis, and mentally competent to complete the interview. Proximal tumors were defined as cecum through transverse colon; and distal tumors were categorized as tumors in the splenic flexure and descending and sigmoid colon. Cases who had adenocarcinoma or carcinoma of the rectosigmoid junction or rectum (first 15 cm from the anal opening) or had known familial adenomatous polyposis, ulcerative colitis, or Crohn's disease were not eligible for the study. Response and participation proportions have been described previously [23] . Of the cases that were asked, 76% participated in the study.
Controls-Controls were frequency-matched to cases by sex, race, and by 5-year age groups. At KPMCP, controls were randomly selected from membership lists. In Utah, controls 65 years and older were randomly selected from the Health Care Financing Administration lists and those younger than 65 years were randomly selected from driver's license lists. In Minnesota, controls were selected from driver's license and stateidentification lists. Of the controls asked, 64% participated [24] .
Data collection
In-person interviews using laptop computers were conducted by trained interviewers to collect diet and lifestyle data. Study quality-control methods have been previously described [25] . For this study, the reference period was the calendar year ~2 years before the date of diagnosis for cases or the date of selection for controls. Information on demographic factors such as age, sex, center, diet, physical activity, height and weight 2 years prior to diagnosis, regular use of aspirin and/or non-steroidal anti-inflammatory drugs (NSAIDs), cigarettesmoking history, and medical history were collected [23] . Study participants were asked to self-report their race/ethnicity. An adaptation of the validated Coronary Artery Risk Development in Young Adults (CARDIA) diet history questionnaire [26] was used to ascertain the participants' dietary intake data. The diet history interview was found to be a reasonably reliable and valid dietary survey method. The interviewers asked participants to determine which foods they had eaten and the frequency with which the foods had been eaten. The nutrients were calculated using the Minnesota Nutrition Coordinating Center's nutrient database version 19. Due to the imprecise measure of nutrient intakes from supplements, stratified analyses were restricted to individuals who indicated no regular intakes of vitamin supplements (1089 cases and 1315 controls) and, thus, reflect total dietary intakes. Participants were also asked to recall activity levels by level of intensity; consumption of alcoholic beverages for the referent year as well as 10 and 20 years ago; and usual number of cigarettes smoked in a day, along with when they started and stopped smoking. Blood was collected during the in-person interview or a clinic visit. Genomic DNA was extracted as described previously [27] .
Genotyping
This study is a comprehensive evaluation of 10 candidate polymorphisms in FOCM, which were chosen on prior evidence regarding their probable impact on protein function. This was based on laboratory or epidemiologic studies, and the in silico prediction tools SIFT [28] [29] [30] and PolyPhen [31] [32] [33] . The DHFR 19bp del, MTHFD1 R134K, MTHFD1 R653Q, and TCN2 P259R polymorphisms were genotyped by allelic discrimination using the 5' nuclease assay on a 7900HT sequence detection system (Applied Biosystems, Foster City, CA) at the Fred Hutchinson Cancer Research Center (FHCRC, Seattle, WA). Genotyping results were validated by genotyping 100 individuals by both 5' nuclease assay and restriction fragment length polymorphism (RFLP) [34, 35] . Four negative controls and at least one positive control were included on each plate. For quality-control purposes, genotyping for 94 randomly selected samples was repeated.
The SHMT1 L474F, DNMT1 I311V, MTHFR R594Q, MTRR H622Y, MTRR I22M, and TDG G199S polymorphisms were genotyped using the Illumina™ GoldenGate bead-based genotyping platform at the Translational Genomics Institute (TGen, Phoenix, AZ). Blinded duplicates were included on all plates. Intraplate and interplate replicates were included at 5%. Genotyping results were confirmed by comparing to genotype data from 30 CEPH trios (Coriell Cell Repository, Camden, NJ) who were genotyped by the HapMap project. Genotypes were excluded for any of the following criteria: GenTrain Score <0.4, 10%GC Score <0.25, AB T Dev >0.1239, Call Frequency <0.85, Replicate Errors >2, P-P-C Errors >2, <85% concordance with blinded or unblinded duplicates or with HapMap genotypes. The genotype frequencies among cases and controls for all polymorphisms were compatible with Hardy-Weinberg equilibrium (χ 2 test).
Data analysis
Heterozygous and homozygous variant genotypes were grouped together (i.e. dominant model) for the analysis of polymorphisms with minor allele frequencies <10%. For genes with multiple polymorphisms (MTHFR C677T (A222V), A1298C (E429A), G1793A (R594Q); MTHFD1 G401A (R134K), A1958A (R653Q) and MTRR G66A (I22M), G401A (R134K)), we also analyzed combined genotypes to estimate the risk of colon cancer and interactions with one-carbon nutrients. Genotypes were grouped into categories according to putative phenotype and the combined major allele-genotype was considered a reference. Unconditional logistic regression models were used to estimate odds ratios (ORs) and corresponding 95% confidence intervals (95% CI) for the association between genotypes and risk of colon cancer. In these models, known risk factors were included as covariates to adjust for potential confounding: age at diagnosis or selection, sex (for models with men and women combined), race/ethnicity, study center, body mass index reported for the referent period, long-term vigorous leisure-time physical activity, total energy intake, dietary fiber, dietary calcium, usual number of cigarettes smoked per day on a regular basis, NSAID use, and hormone replacement therapy [21] .
Categories for the different dietary exposures were calculated from the distribution of the control population and for men and women separately. Approximate tertile cut-points were used to designate categories of dietary intake. Smoking behavior was categorized as: never smoked regularly; ≤20 cigarettes/day; or >20 cigarettes/day [16] . High-or low-risk onecarbon dietary pattern was based on tertile intake of folate and methionine and long-term alcohol consumption as defined previously [16] . Because supplement use was only qualitatively assessed in the study, we restricted these analyses to individuals without relevant supplement use. Less than 1% reported taking individual supplements of folate, vitamin B 6 and vitamin B 12 and about 1% reported taking a B complex supplement.
Interactions between genotypes and diet on the risk of colon cancer were evaluated by testing for different slopes associated with nutrient intake across genotype. All statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC).
RESULTS
Characteristics of the study population and polymorphism genotype frequencies are presented in Table 1 by case and control status. The study participants predominantly selfidentified as Caucasian (92%), with the remainder self-identified as Hispanic (4%) or African-American (4%). Although allele frequencies for African-Americans were statistically significantly different from those of Caucasians or Hispanics (data not shown), stratification by race was not useful in determining associations for African-American participants due to the small sample size and imprecise estimates. The distribution of all genotypes among African-Americans or Hispanics did not differ between cases and controls. When we restricted our analysis to Caucasians, the results did not differ, thus we included all individuals in our analysis and adjusted for ethnicity.
Main associations
No statistically significant association between any of the 10 candidate polymorphisms and overall colon cancer risk was observed ( Table 2 ). Stratifying by sex did not alter these associations. However, when stratified by age, statistically significant associations were found in women for the MTHFD1 R134K variant (p=0.03) and in men for the MTHFR R594Q variant (p=0.02) (data not shown).
Dietary interactions
The major focus of this study was the investigation of potential interactions between 10 candidate polymorphisms in FOCM-related genes and dietary factors relevant to FOCM (folate, methionine, one-carbon dietary pattern, vitamin B 2 , vitamin B 6 , and vitamin B 12 ) (data not shown). Analyses were performed in men and women separately, as well as combined. Statistically significant interactions are shown in Table 3 . A summary of all observed associations is provided in Table 4 .
The DNMT1 I311V variant was associated with a decreased risk of colon cancer among individuals with low dietary folate intake (OR=0.6; 95% CI=0.4-1.0) and a trend towards increased risk with moderate intake (p-interaction=0.04). Likewise, the variant was associated with a decreased risk of colon cancer in combination with low dietary methionine intake in women (OR=0.4; 95% CI=0.2-1.0), whereas high methionine reversed the association (p-interaction=0.04). In addition, DNMT1 I311V showed statistically significant interactions with vitamin B intake. Low dietary vitamin B 2 or B 12 intake was inversely associated with colon cancer risk among variant carriers (B 2 : OR=0.5; 95% CI=0.3-0.9; B 12 : OR=0.6; 95% CI=0.4-0.9), whereas an increased risk was observed with higher vitamin B 2 or B 12 intake (B 2 : p-interaction=0.02, B 12 : p-interaction=0.05). These associations were largely explained by associations in women.
The second variant which showed statistically significant interactions with several dietary factors in the modification of colon cancer risk was MTRR I22M. Women homozygous for the variant were at an increased risk of developing colon cancer when their dietary folate intake was low (OR=2.2; 95% CI=1.1-4.2), whereas the risk decreased with high dietary folate intakes (p-interaction=0.02). A similar trend was observed for the one-carbon dietary pattern. Heterozygous women were at decreased risk when grouped in the lowest tertile of the one-carbon dietary pattern, whereas the risk increased for women with the same genotype grouped in the highest tertile (p-interaction=0.02). Moreover, the variant showed statistically significant interactions with vitamin B 6 intake. The variant was associated with increased risk of colon cancer for women with low vitamin B 6 intake (OR=3.0; 95% CI=1.5-6.0), whereas moderate intake decreased the risk of the disease (p-interaction=0.01).
The SHMT L474F polymorphism showed a statistically significant interaction (p-interaction <0.001) with methionine intake among women. The variant was associated with an increased risk of colon cancer in combination with moderate methionine intake, whereas the risk decreased with high methionine intake. A statistically significant interaction with this variant was also observed for dietary vitamin B 2 intake in men (p-interaction=0.03). Variant carriers who consumed the lowest amounts of vitamin B 2 were at higher risk compared to men with the same genotype but with moderate vitamin B 2 intake.
The analysis of the 19bp deletion polymorphism in the DHFR gene revealed a statistically significant interaction with methionine intake (p-interaction=0.01). An increased risk of colon cancer was observed for male variant carriers with moderate methionine intake (OR=1.7; 95% CI=1.0-3.0), whereas the risk of the disease showed a decreasing trend in variant carriers with a high methionine intake. A statistically significant interaction with this variant was also observed for the one-carbon dietary pattern in men (p-interaction=0.04). Men who were homozygous for the deletion were at statistically significantly decreased risk of colon cancer when grouped in the lowest tertile of the one-carbon dietary pattern (OR= 0.3; 95% CI=0.1-0.8), whereas the risk increased when grouped in the highest tertile.
There were few interactions for the MTHFD1, variants, except for MTHFD1 R134K with dietary vitamin B 6 intake among women (p-interaction=0.01) and MTHFD1 R653Q with dietary methionine intake (p-interaction=0.01) in both men and women. Finally, the MTHFR R594Q polymorphism showed a statistically significant interaction with dietary folate intake among women only (p-interaction=0.03).
We investigated combined genotypes for MTHFR, MTRR, and MTHFD1, to account for multiple polymorphisms in one gene. There were few statistically significant interactions (e.g., MTRR x high-risk dietary-pattern in men, p=0.03). However we consider these spurious, because sample sizes were low and patterns in the other sex or overall were not consistent.
DISCUSSION
For many years, diet has been recognized as an important modifiable factor that influences colorectal cancer risk and prevention. However, the exact underlying mechanisms are complex and are often modified by genetic predisposition. Understanding the interaction between nutrition and genetic variation is useful to distinguish between individuals who will and who will not benefit from diet intervention strategies. Folate and the FOCM are of special interest to colon and rectal cancer, as they are involved in DNA maintenance, repair and methylation. To further investigate the impact of FOCM on colon carcinogenesis, we investigated the associations between risk of colon cancer and polymorphisms in candidate genes involved in FOCM, namely DHFR, DNMT1, MTHFD1, MTHFR, MTRR, SHMT, TCN2, and TDG, with a special focus on dietary interactions in a large case-control study.
Overall, we observed no association between any of the investigated polymorphisms and colon cancer risk; however, several polymorphisms modified the risk of colon cancer in interacting with dietary intakes of folate, methionine, vitamin B 2 , vitamin B 6 , vitamin B 12 , or the one-carbon dietary pattern as previously defined [16] . In particular, the variants DNMT1 I311V and MTRR I22M showed multiple statistically significant diet interactions.
DNMT1 is involved in the establishment and regulation of tissue-specific methylation of cytosine residues. The investigated DNMT1 I311V polymorphism, though predicted to be benign (PolyPhen-score: 0.826) and tolerated (SIFT-score: 0.46), leads to an amino acid change and may alter the properties of the protein. Concordant with our findings, a previous study on DNMT I311V and colon cancer risk did not observe any associations with overall colon cancer risk [36] . However, in this study, we observed that DNMT1 I311V significantly modified the risk of colon cancer interacting with dietary folate, methionine, vitamin B 2 and vitamin B 12 intake. The interaction of the variant with vitamin B 12 intake may be explained by increased synthesis of methionine, resulting in higher B 12 levels, which in turn is converted to S-adenosylmethionine (SAM). Higher SAM levels, as a substrate for DNMT1, could result in increased DNMT1 activity and enhanced abnormal DNA methylation, thus, increasing the risk of colon cancer. However, a recent study that investigated the effect of DNMT1 I311V on risk of rectal cancer, including gene-diet interactions, did not observe any associations with disease risk [37] , consistent with the notion colon cancer and rectal cancer are distinct diseases.
The second polymorphism that modified the risk of colon cancer in association with several dietary factors (dietary folate, vitamin B 6 , and the one-carbon dietary pattern) was MTRR I22M. MTRR triggers the reactivation of methionine synthase via reductive methylation and, thus, acts at the junction between the folate and methionine cycles. Kinetic investigations of the functional properties of the MTRR variant enzyme revealed a decreased affinity of the protein to methionine synthase [38] . The observed statistically significant interaction between the MTRR I22M variant and vitamin B 6 intake was consistent with a previous study on CRC, whereas two other studies, one of colorectal and one of rectal cancer did not observe any statistically significant interactions [37, 39, 40] . Based on its described functions, we expected to observe an interaction of the MTRR variant with both dietary folate and methionine intake; however, an interaction was observed only with folate. We also observed that the defined one-carbon dietary pattern modified the association between colon cancer risk and MTRR I22M in women, which is consistent with the decreased risk observed between variant genotypes and high folate intake in women.
SHMT triggers the synthesis of 5,10-methylene tetrahydrofolate, using vitamin B 6 as a cofactor. The ability of the variant enzyme to form a functional holo-enzyme is decreased [41] . We expected to find an interaction between SHMT L474F and both vitamin B 6 and folate intake, which, consistent with a previous study on colon cancer [42], was not observed. However, we observed a statistically significant interaction between SHMT L474F and dietary methionine intake in women and with vitamin B 2 intake in men, which has not been previously reported.
Our investigation of the DHFR 19bp deletion showed no interaction with folate intake. DHFR reduces folic acid (the synthetic form of folate used in supplements) to dihydrofolate (DHF), allowing DHF to enter the FOCM pathway; however, it is not relevant in the absorption of natural reduced folate from dietary sources. A study on breast cancer has reported decreased DHFR mRNA levels with the deletion and increased risk of breast cancer for women carrying the deletion and taking multivitamin supplements [43] . Our investigation of the DHFR 19bp deletion showed statistically significant interactions of the polymorphism with methionine intake and with the dietary-pattern-defined risk groups. As DHFR is linked to 5-methyl-THF, the primary methyl donor for methylating homocysteine to methionine, abnormalities in the methylation process due to variation in enzyme activity may alter carcinogenesis.
Two candidate polymorphisms in the MTHFD1 gene were investigated within this study, both showing interactions with different dietary groups. The association between colon cancer risk and the MTHFD1 R134K was modified by vitamin B 6 intake in women, which was also predicted due to its function as a cofactor for SHMT. In men, however, an opposite trend was observed, suggesting that these findings may be spurious. The MTHFD1 R653Q variant allele interacted with methionine intake, but not with folate or vitamin B 6 . The variant allele is associated with decreased enzyme activity [44] and it has been shown that heterozygous individuals are at a decreased risk for hyperplastic polyps [45] . A study of rectal cancer did not find any association of the variant with overall risk or in combination with FOCM-related nutrients [37] .
MTHFR catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which is a co-substrate for remethylation of homocysteine to methionine. We had previously reported that the combined genotypes of MTHFR 677CC/ 1298AA (wild-type/wild-type or heterozygous/wild-type) were associated with a trend towards reduced risk of colon cancer among women with a high folate intake [21] . Similarly, in this study a statistically significant interaction between MTHFR R594Q and folate intake was observed in women. The functional significance of the R594Q polymorphism is currently unknown. Although PolyPhen predicts it to be possibly damaging (score: 1.746), while SIFT does not (score: 1.00). A study by Xu et al. showed that, among Chinese women with high dietary folate intake, the R594Q variant allele was associated with a lower risk of endometrial cancer than those with a wild type allele and low folate intake [46] . The minor allele frequency of MTHFR R594Q is only 5%; thus, larger studies need to confirm the association of this polymorphism with colon cancer risk.
This study highlights the importance of investigating the joint effect of genetic susceptibility and nutrients. We did not observe any significant association between the individual polymorphisms with functional impact on FOCM and risk of colon cancer; however, including nutrient intake in our investigation, we observed several relevant gene-diet interactions. Our summary table suggests that for some functional genetic variants in FOCM (e.g. DNMT I311V or MTRR I22M) nutrient intake "matters" and, thus, that these genetic polymorphisms deserve more attention in nutrigenetic strategies.
A strength of the present case-control study is the large sample size, which allowed us to investigate gene-diet interactions more reliably. The diet interviews were based on a comprehensive validated instrument which provides support for valid assessment. However, we recognize that, given the focused referent year, long-term dietary changes may not be captured. Another limiting factor was the small number of individuals in some strata, which could lead to imprecise estimates. We investigated specific hypotheses with respect to putative gene-diet interactions; thus, we did not adjust for multiple comparisons, yet we recognize that some associations are likely to be spurious.
In summary, this study shows that genetic polymorphisms in genes relevant to the FOCM pathway may interact with intakes of one-carbon metabolism nutrients. Our results provide support for the hypothesis that dietary intakes modify the association between colon cancer risk and the two candidate polymorphisms, DNMT1 I311V and MTRR I22M. The interactions observed were consistent with our hypotheses. Furthermore, variants in SHMT, DHFR, MTHFD1, and MTHFR modified susceptibility to colon cancer based on dietary consumption of folate, methionine, and vitamins B 2 and B 6 . The findings of this study add to the present understanding that folate-related gene-nutrient interactions play an important role in the risk of colon cancer and should be considered in diet intervention strategies. Further research needs to be conducted to test our results and to contribute further to establishing which diet/allele interactions are crucial to the role of folate-mediated onecarbon metabolism in colon carcinogenesis. Characteristics and genotype of the study population (4) 73 ( Table 2 Association between polymorphism genotypes and colon cancer risk, stratified by sex a) P interaction -0.44 a) Adjusted for age, race/ethnicity, center, body mass index, lifetime vigorous activity, energy intake, dietary fiber, dietary calcium, usual number of cigarettes smoked, NSAID use, and hormone replacement therapy. Participants with missing data for any of these variables were excluded. Combined analyses were also adjusted for sex. Table 3 Significant associations between polymorphism genotypes and colon cancer risk, stratified by dietary factors a) 
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